VANCOUVER, BC, CANADA, January 15, 2026 / EINPresswire.com / — Eyam Health and iiDiagnostics (iiDX), a company formed by the Infection Innovation Consortium: iiCON, have launched a collaboration to ...

A large, multidisciplinary team led by researchers from Texas A&M University has made a potentially game-changing discovery ...

A large, multidisciplinary team led by researchers from Texas A&M University has made a potentially game-changing discovery about the development of devastating motor neuron diseases like amyotrophic ...

Previous research has implicated fungi in chronic neurodegenerative conditions such as Alzheimer’s disease, but there is limited understanding of how these common microbes could be involved in the ...

The Hull York Medical School is behind a trial which aims to revolutionise infection management and improve the outcomes of ...

A study published in Nature looks at genetic determinants of persistent Epstein-Barr virus DNA and associations with chronic conditions. Prof Lawrence Young, Virologist and Emeritus Professor of ...

Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP ...

During the pandemic, one very clear tragedy stood out: Approximately 200,000 residents and staff died from COVID-19 in nursing homes. However, what many people don’t realize is that even before the ...